Lupin, PlushCare expand access to Bacterial Vaginosis Treatment to Meet Patient Needs amid COVID crisis
"With the current healthcare landscape, more people are turning to telehealth than we've ever seen before," said Ryan McQuaid, CEO, and Co-Founder of PlushCare. "We are thrilled that Lupin Pharmaceuticals has chosen to partner with us to help women gain access to BV treatment with greater ease.";
Baltimore: Lupin Pharmaceuticals Inc., the U.S. based wholly-owned subsidiary of Lupin Limited, and PlushCare, a virtual doctor's appointment service, have announced an agreement to allow treatment for bacterial vaginosis (BV) in adult women, via the PlushCare virtual platform.
PlushCare enables patients to easily book a virtual doctor's appointment, discuss symptoms, receive a prescription for lab testing and treatment, if necessary.
Bacterial vaginosis is the most common vaginal infection in the U.S. affecting more than 20 million women between the ages of 14 and 49 annually. Symptoms of BV include an unpleasant or fishy odor, a thin milky greyish-white discharge, or excessive discharge, and sometimes itching, burning sensation or irritation. However, some women may have no symptoms. BV is treated with a prescription antibiotic, and if untreated, is associated with an increased risk of pelvic inflammatory disease, HIV, and other sexually transmitted infections.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.